Hennion & Walsh Asset Management, Inc. Ascendis Pharma A/S Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 6,975 shares of ASND stock, worth $995,890. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,975
Previous 7,034
0.84%
Holding current value
$995,890
Previous $1.06 Million
10.54%
% of portfolio
0.05%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.44 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$709 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$613 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$599 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$560 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.97B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...